Literature DB >> 1357456

Fatal myocardial infarction and use of psychotropic drugs in young women.

M Thorogood1, P Cowen, J Mann, M Murphy, M Vessey.   

Abstract

We have observed an unexpected 17-fold increase in risk of fatal [corrected] myocardial infarction (relative risk 16.9, 95% confidence interval 3.9-72.8) associated with current use of psychotropic drugs. This incidental finding, in a case-control study of cardiovascular mortality in women aged 16-39 not designed to test any hypothesis about psychotropic drugs, should be treated cautiously. There is, however, evidence of a relation between psychiatric morbidity and cardiovascular disease and the association recorded here requires further investigation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1357456     DOI: 10.1016/0140-6736(92)93081-w

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  19 in total

Review 1.  Antipsychotic-induced venous thromboembolism: a review of the evidence.

Authors:  Staffan Hägg; Olav Spigset
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

Review 2.  Use of antipsychotics and risk of myocardial infarction: a systematic review and meta-analysis.

Authors:  Zheng-He Yu; Hai-Yin Jiang; Li Shao; Yuan-Yue Zhou; Hai-Yan Shi; Bing Ruan
Journal:  Br J Clin Pharmacol       Date:  2016-05-23       Impact factor: 4.335

3.  History of manic and hypomanic episodes and risk of incident cardiovascular disease: 11.5 year follow-up from the Baltimore Epidemiologic Catchment Area Study.

Authors:  Christine M Ramsey; Jeannie-Marie Leoutsakos; Lawrence S Mayer; William W Eaton; Hochang B Lee
Journal:  J Affect Disord       Date:  2010-06-08       Impact factor: 4.839

4.  Heart rate analysis in 24 patients treated with 150 mg amitriptyline per day.

Authors:  T Rechlin; D Claus; M Weis
Journal:  Psychopharmacology (Berl)       Date:  1994-09       Impact factor: 4.530

5.  Over-the-counter and prescription sleep medication and incident stroke: the REasons for Geographic and Racial Differences in Stroke study.

Authors:  Megan E Petrov; Virginia J Howard; Dawn Kleindorfer; Michael A Grandner; Jennifer R Molano; George Howard
Journal:  J Stroke Cerebrovasc Dis       Date:  2014-08-10       Impact factor: 2.136

6.  Use of benzodiazepines and cardiovascular mortality in a cohort of women aged over 50 years.

Authors:  Sylvie Mesrine; Gaëlle Gusto; Françoise Clavel-Chapelon; Marie-Christine Boutron-Ruault; Agnès Fournier
Journal:  Eur J Clin Pharmacol       Date:  2018-07-04       Impact factor: 2.953

Review 7.  Cardiovascular adverse effects of antipsychotic drugs.

Authors:  N A Buckley; P Sanders
Journal:  Drug Saf       Date:  2000-09       Impact factor: 5.606

8.  Increased risk of ischaemic heart disease mortality in elderly men using anxiolytics-hypnotics and analgesics. Results of the 10-year follow-up of the prospective population study "Men born in 1914", Malmo, Sweden.

Authors:  J Merlo; B Hedblad; M Ogren; J Ranstam; P O Ostergren; A Ekedahl; B S Hanson; S O Isacsson; H Liedholm; A Melander
Journal:  Eur J Clin Pharmacol       Date:  1996       Impact factor: 2.953

Review 9.  Mortality Risk of Hypnotics: Strengths and Limits of Evidence.

Authors:  Daniel F Kripke
Journal:  Drug Saf       Date:  2016-02       Impact factor: 5.606

10.  General population based study of the impact of tricyclic and selective serotonin reuptake inhibitor antidepressants on the risk of acute myocardial infarction.

Authors:  L J Tata; J West; C Smith; P Farrington; T Card; L Smeeth; R Hubbard
Journal:  Heart       Date:  2005-04       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.